US Drug Recall Register

Is Pine recalled?

Yes — there is an active recall. 82 ongoing FDA recalls mention Pine (685 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Pine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.

Class II · Moderate risk Terminated

Sodium Tetradecyl 1% Injection

Reason Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Health Innovations Pharmacy, Inc D-1002-2015
Class II · Moderate risk Terminated

Methylcobalamin 1000 mcg/mL Injection

Reason Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Health Innovations Pharmacy, Inc D-1001-2015
Class II · Moderate risk Terminated

Cyanocobalamin 2000mcg/1ml Injection

Reason Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Health Innovations Pharmacy, Inc D-1000-2015
Class II · Moderate risk Terminated

HCG 1000 Units/mL Injection

Reason Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Health Innovations Pharmacy, Inc D-0999-2015
Class II · Moderate risk Terminated

17-HP Hydroxyprogesterone 250mg/1ml Injection

Reason Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Health Innovations Pharmacy, Inc D-0998-2015
Class III · Low risk Terminated

Nicardipine Hydrochloride Injection

Reason Subpotent Drug and Failed Impurities/Degradation Specifications

Mylan Institutional LLC NDC 67457-224-10 D-0413-2015
Class III · Low risk Terminated

Eye Drops Advanced Relief

Reason CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-GMP compliant warehouse at S.I.M.S., Italy.

K C Pharmaceuticals Inc D-0323-2015
Class III · Low risk Terminated

Eye Drops A.C.

Reason CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-GMP compliant warehouse at S.I.M.S., Italy.

K C Pharmaceuticals Inc D-0321-2015
Class III · Low risk Terminated

Eye Drops

Reason CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-GMP compliant warehouse at S.I.M.S., Italy.

K C Pharmaceuticals Inc D-0320-2015
Class II · Moderate risk Terminated

Reserpine active pharmaceutical ingredient packaged in varying…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-877-2015
Class II · Moderate risk Terminated

Quetiapine Fumarate active pharmaceutical ingredient packaged in…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-873-2015
Class II · Moderate risk Terminated

Oxcarbazepine active pharmaceutical ingredient packaged in…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-828-2015
Class II · Moderate risk Terminated

Nevirapine active pharmaceutical ingredient packaged in varying…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-816-2015
Class II · Moderate risk Terminated

Mirtazapine active pharmaceutical ingredient packaged in varying…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-801-2015
Class II · Moderate risk Terminated

Homatropine Methylbromide active pharmaceutical ingredient…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-707-2015
Class II · Moderate risk Terminated

Epinephrine active pharmaceutical ingredient packaged in varying…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-650-2015
Class II · Moderate risk Terminated

Clozapine active pharmaceutical ingredient packaged in varying…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-598-2015
Class II · Moderate risk Terminated

Benztropine Mesylate active pharmaceutical ingredient packaged in…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-539-2015
Class II · Moderate risk Terminated

Atropine Sulfate Monohydrate USP active pharmaceutical ingredient…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-529-2015
Class II · Moderate risk Terminated

Amlodipine besylate active pharmaceutical ingredient packaged in…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-518-2015
Class II · Moderate risk Terminated

Amlodipine active pharmaceutical ingredient packaged in varying…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-517-2015
Class III · Low risk Terminated

Carbamazepine Tablets USP

Reason Marketed without an Approved NDA/ANDA: One lot was on hold-pending release status when it was erroneously made available for sale in the inventory control system. An alternate manufacturing site for the Carbamazepine API final intermediate was pending approval.

Taro Pharmaceuticals U.S.A., Inc. NDC 51672-4005-3 D-0049-2015
Class II · Moderate risk Terminated

Epinephrine 1:1000

Reason Lack of Assurance of Sterility: A recent FDA inspection of Vann Healthcare Services facility revealed deficiencies that raise concerns about the pharmacy's ability to consistently assure sterility of their products.

Vann Healthcare Services Inc D-0310-2015
Class II · Moderate risk Terminated

Epinephrine/Water

Reason Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Oregon Compounding Centers, Inc. dba Creative Compounds D-0188-2015
Class III · Low risk Terminated

Amlodipine Besylate Tablets

Reason Discoloration: Brown spots were noted embedded in Amlodipine Besylate Tablets, 10 mg, Lot # MP4344.

Zydus Pharmaceuticals USA Inc NDC 68382-123-16 D-0257-2015